The effect of low-dose (15 ml/kg) intracoronary perfluorochemical (Fluosol-DA) on infarct size, regional myocardial blood flow, and ventricular function was studied in 20 anesthetized closed-chest dogs subjected to 11/2 hr of proximal left anterior descending occlusion. In this preparation reperfusion was simulated with fibrinolytic therapy. The animals were randomly assigned one of two treatment groups and given 15 ml/kg of either oxygenated intracoronary perfluorochemical (n = 9) or saline (n = 1 1). Contrast ventriculograms were obtained at baseline, 1 hr after occlusion, and at 24 hr after reperfusion and were analyzed with a radial fractional shortening method. Regional myocardial blood flow was measured with radioactive microspheres. At 24 hr the area at risk was defined in vivo with monastryl blue staining and the area of necrosis was estimated after incubation of left ventricular slices with triphenyltetrazolium chloride. No significant changes were noted in heart rate, blood pressure, pulmonary capillary wedge pressure, or dP/dt during the experimental protocol. Infarct size was significantly reduced (p < .02) in the perfluorochemical-treated group, both when expressed as a percentage of the total left ventricular mass (7.9 + 1.7% vs 14.7 ± 2.5%) and as a percentage of the area at risk (20.1 ± 5.0% vs 46.8 + 8.5%). This was associated with significant improvement in fractional shortening in the jeopardized zone at 24 hr after reperfusion. Although endocardial blood flow was significantly greater in the central ischemic zone and lateral region at risk immediately after reperfusion in the perfluorochemical-treated group, no difference was found 1 hr after reperfusion. Intracoronary perfluorochemical significantly reduces infarct size and improves regional contractile function in a preparation of occlusion-reperfusion without increasing left ventricular filling pressure.
MEDICAL REPERFUSION with thrombolytic therapy has been shown to reduce infarct size and improve ventricular function in both experimental preparations and in man. -10 However, reperfusion can result in morphologic and metabolic derangements (so-called reperfusion injury) that may reduce the amount of myocardium that can be salvaged.1 I"' Perfluorochemicals are substances that may be useful in treating ischemia because of their high oxygen-carrying capacity. [19] [20] [21] [22] Reduction of infarct size with perfluorochemicals has been shown by others,23 27 but previously the drugs were either used in a preparation of permanent occlusion or were studied only after brief periods of ischemia. Since large intravenous doses of perfluorochemicals were used in these studies, an exchange blood transfusion was required to prevent volume overload. This study was designed to determine whether a low dose of intracoronary perfluorochemical in an occlusion-reperfusion preparation results in greater reduction of infarct size than reperfusion with saline alone. We also determined the effect of perfluorochemical (Fluosol-DA 20%,* which has been approved for clinical trials in severe anemia20' 28) on regional myocardial blood flow and contractile state as assessed by fractional shortening.
Methods
Surgical preparation. Thirty-five mongrel dogs of both sexes weighing 20 to 25 kg were randomly assigned to receive either perfluorochemical or saline, anesthetized with intravenous sodium pentobarbital (Nembutal, 25 to 30 mg/kg), and *Alpha Therapeutic Corporation, Pasadena, CA.
intubated and ventilated with a Harvard positive-pressure respirator using room air. After thoracotomy the left anterior descending artery of each dog was isolated distal to the first diagonal and a snare (surgical monofilament) enclosed in a polyethylene sleeve tubing (PE 320-0) was implanted and anchored to the epicardium with two small sutures. In addition, a separate polyethylene pediatric feeding tube (National Catheter Company No. 85773) was inserted into the left atrial appendage and heparinized. The pericardium and chest were then closed and both lines were buried in a subcutaneous pocket in the left subscapular region.
Experimental protocol (figure 1). Dogs were allowed to recover for 5 to 7 days. Each animal was reanesthetized with 30 mg/kg iv phenobarbital, intubated with a cuffed endotrachial tube, and ventilated with a Harvard positive-pressure respirator maintaining an arterial pH of 7.40 + 0.05. The studies were performed after the dogs had been stable for 1 hr. Adequate anesthesia (lack of corneal reflex) was maintained during the study with a combination of 7.5 mg iv morphine and 5 mg iv diazepam, as required. Electrocardiographic leads I and aVF, and a precordial chest lead were recorded. Phasic and mean arterial pressure was measured with either a No. 7F pigtail catheter or No. 7F modified left Judkins catheter introduced into the femoral artery via a No. 7F Cordis sheath. A Millar micromanometer-tipped catheter, introduced via a No. 5 Cordis sheath into the opposite femoral artery, measured dP/dt. A No. 7F Swan-Ganz catheter was inserted via the right femoral vein into the pulmonary artery. The snare and left atrial line were then retrieved through a subcutaneous incision.
Baseline measurements of phasic and mean arterial blood pressure, pulmonary arterial and capillary wedge pressures, dP/dt, and thermodilution cardiac output were then recorded. Regional myocardial blood flow was determined at baseline and serially with injections of 15 ,um microspheres labeled with '41Ce, 51Cr, 85Sr, and 16Sc (3M Company, St. Paul, MN) at -2 x 106 microspheres/injection by the atrial line. Femoral arterial samples were collected to allow calculation of myocardial blood flow in milliliters per minute per gram. A baseline ventriculogram was obtained in the right anterior oblique view with 10 ml of meglumine diatrizoate injected through a power injector. Blood samples were drawn at baseline, 1 hr after occlusion, at reperfusion, and at 3 and 24 hr after reperfusion for determination of the following: pH, hematocrit, total white cell count, Po2, Pco2, partial thromboplastin time (PTT), and total creatine kinase (CK). Each dog was then given 1 mg/kg lidocaine before the ligation of the snare and on its release. After 1 hr of occlusion all hemodynamic measurements were repeated, myocardial blood flow was determined, and a contrast ventriculogram was obtained. Perfluorochemical or saline was then bubbled with 100% oxygen at a rate of 2 liters/min for1/2 hr before infusion.
PROTOCOL
After 11/2 hr the snare was gradually released over 5 min and 30,000 units of intracoronary streptokinase was given. The dogs were ventilated with 100% oxygen and this was continued for 3 hr after reperfusion. Patency of the left anterior descending artery was confirmed by selective left coronary artery injection of contrast material. In this preparation reperfusion was simulated with fibrinolytic therapy. Immediately after completion of infusion of streptokinase, animals were given 15 ml/kg oxygenated saline or oxygenated perfluorochemical (Fluosol-DA) by the intracoronary route (dog weight 20kg x 15 ml/kg = 300 ml drug or saline) over 20 to 30 min according to the protocol. The infusion was given into the left main coronary ostium. Hemodynamic measurements were made and blood samples were drawn after the perfluorochemical or saline infusions and at 1, 2, and, 3 hr after reperfusion. Regional myocardial blood flow was determined immediately and at 1 hr after reperfusion. Dogs were then removed from the respirator, given antibiotics, and allowed to recover. After 24 hr the animals were reanesthetized and ventriculography was repeated with the dogs in a position similar to that at baseline. The snare was retrieved and ligated. The mid point of this axis was determined and radii were constructed from the mid point to the edge of the ventricular silhouette at 10 degree intervals (36 radii). Percent shortening of each radius was calculated according to the following formula: percentage shortening = (end-diastolic lengthsystolic length)/ (end-diastolic length x 100). Radial axes 1 to 3 and 31 to 36 were excluded from analysis since they involved the mitral and aortic valves. The ischemic zone was determined from the largest number of radii that were asynergic and/or dysynergic at occlusion and at 24 hr. Improvement in a given radius was defined as an absolute increase of greater than 10% in that radius. Intraobserver error with this method was 1.0 + 0.3%.
Calculation of myocardial blood flow. Samples for deter-Vol. 71, No. 5, May 1985 1061 Values are mean ± SEM. PLT = platelet count; TLC = total leukocyte count; 3 hr = 3 hr after reperfusion. mination of regional myocardial blood flow were obtained from endocardial and epicardial sections (0.3 to 1.0 g) in the nonischemic area (posterior wall), in the center of the infarct (unstained by TTC), and in the lateral region at risk. Samples were obtained from a proximal and distal left ventricular slice. Myocardial sections and arterial reference samples were counted in a multichannel analyzer (Auto Gamma scintillation spectrometer, model 5986, Packard Instrument Company, Inc., Downers Grove, IL) and myocardial blood flow was determined (in ml/min/g dry weight) by methods previously described in our laboratory.31 To reduce the serial fluctuations in control flows, we normalized myocardial blood flow.
Statistical analysis. All data are presented as mean + SEM.
Data from successive time points in the two groups were tested by analysis of variance followed by Duncan's multiple-range 1062 test. Intergroup comparisons of infarct size were performed by Student's t test for unpaired data. Probability values of .05 or less were required for assumption of statistical significance.
Results
Of the 36 dogs that underwent coronary arterial occlusion 12 (six in each group) were excluded because they developed ventricular fibrillation during the initial 20 min after occlusion or during reperfusion. In three animals reperfusion failed and one additional animal was excluded because infarct size was less than 1 % of the area at risk. Data from the remaining 20 dogs are the basis for this report: nine received perfluorochemical (Fluosol-DA) and 11 received the control solution.
Laboratory and hemodynamic changes (tables 1 and 2).
Pao2 values were comparable in the perfluorochemical (416 52 mm Hg) and control (387 25 mm Hg) groups at 3 hr after reperfusion. No significant differences were noted in total leukocyte count, platelet count, or PTT or total CK values between the two groups.
Heart rate, arterial pressure, pulmonary capillary wedge pressure, dP/dt, and cardiac output were similar in the two groups before occlusion. After occlusion, arterial pressure, dP/dt, and cardiac output fell to a similar extent in both groups. Although pulmonary capillary wedge pressure was slightly higher in the perfluorochemical group during the 3 hr postreperfusion period, this change did not reach statistical significance. No significant changes were noted in the hemodynamic parameters during or in the 3 hr after reperfusion in the two treatment groups. Although not significant, cardiac output tended to be higher in the perfluorochemical-treated group as compared with the control group 3 hr after reperfusion (2.6 + 0.2 vs 2.0 ± 0.2 liters/min; NS).
Effect of perfluorochemical on infarct size (table 3 ). The mass of the region at risk was significantly larger in the perfluorochemical-treated animals (39.2 ± 3.0 vs 25.0 ± 4.7 cm3; p < .02), but infarct size expressed both as a percentage of the left ventricular mass and as a percentage of the risk region was significantly reduced in the perfluorochemical-treated group as compared with the control animals. Percentage of myocardium at risk that became infarcted was 20.1 ± 5.2% in the perfluorochemical group and 46.8 ± 8.5% in the control group (p < .02). Examples of areas of infarct and areas at risk in a control and perfluorochemicaltreated animal are shown in figure 2 . In both groups the infarcts were confined to the subendocardium, but in animals treated with perfluorochemical the infarcts were smaller and patchier.
Results of contrast ventriculography (table 4, figure 3 ).
The number of radii in the ischemic zone and the percentage of radial fractional shortening at baseline in this zone were similar in the two groups. Fractional shortening at 1 hr after occlusion in the ischemic zone was similarly and significantly reduced in both treatment groups. However, at 24 hr the control group failed to demonstrate any improvement in fractional shortening in the ischemic zone, while the perfluorochemical group demonstrated a significant improve-Vol. 71, No. 5, May 1985 ment (-2.6 ± -0.7 to 5.0 ± 2.0; p < .02). This was also associated with greater (although not significantly so) improvement in the number of radii at 24 hr (2.0 vs 5.5; NS). Regional myocardial blood flow ( figure 4 ). Data on regional myocardial blood flow were available in 16 of 20 dogs (eight in each group). At occlusion flow decreased similarly in the central ischemic zone in both the epicardium and endocardium in the two groups. Relative endocardial blood flow was significantly greater immediately after reperfusion with perfluorochemical compared with after saline in both the central and lateral zones. This difference was not maintained 1 hr after reperfusion. No significant changes were noted in absolute or relative flow in the nonischemic zone (posterior wall) or in the epicardial lateral region at risk.
Discussion
Effects of reperfusion. Medical reperfusion with thrombolytic therapy has been shown to reduce infarct size in the canine preparation.2-6 In man increased thallium uptake was demonstrated by Markis et al.32 soon after reperfusion, suggesting increased cellular viability in the infarct region. Successful reperfusion results in improved ventricular function in both animals and man.3' 7-10, 33, 34 However, reperfusion may result in some metabolic and anatomic derangements in the early reperfusion period1' 16; anatomic changes include marked cellular swelling and disruption, calcium accumulation, and subendocardial hemorrhage. Hemorrhage does not appear to be an important factor in limiting myocardial salvage since it occurs only in areas of irreversible necrosis.6' 35 Reperfusion is also associated with introduction of large quantities of oxygen at a time of accelerated loss of enzymes, including free radical-metabolizing enzymes, from the myocardial cell. 17 ' 18 Oxygen-free radicals accumulate within ischemic tissue and these have been implicated in reperfusion injury.17 118 Free-radical enzyme scavengers have been shown to reduce infarct size if given before or soon after reperfusion in a dog preparation and have also been shown to limit mitochondrial injury in vitro.17' 18 Since in most studies of experimental agents shown to limit infarct size a permanent occlusion preparation has been used, we attempted to determine whether perfluorochemical would enhance myocardial salvage in a preparation in which reperfusion was simulated with fibrinolytic therapy.
Perfluorochemical. Perfluorochemicals are inert substances of low viscosity that will dissolve as much or more oxygen and carbon dioxide as whole blood.19 36 FIGURE 2. Ventricles were sliced at 1 cm intervals parallel to the posterior atrioventricular sulcus and the area at risk was defined by nonstaining of the myocardium by monastryl blue. The area of infarction was defined by the TTC staining, with noninfarcted myocardium staining deep red and infarcted area appearing creamy white (arrows). Animal treated with saline (A) had significantly larger infarcts than animals treated with perfluorochemical (B).
Unlike hemoglobin, the oxygen content of perfluorochemicals rises in linear fashion with an increase in oxygen tension and a high arterial oxygen is essential for perfluorochemicals to transport quantities of oxygen comparable to those transported by red blood cells.25 36 One preparation of perfluorochemical (Fluosol-DA 20%) has been used successfully in the United States and Japan in anemic patients as a blood substitute. 20 25 Studies in several animal preparations have suggested that use of perfluorochemicals may be an effective form of therapy for reducing experimental myocardial ischemia.23 27 Prevention of myocardial ischemia for up to 45 min has also been demonstrated during percutaneous transluminal balloon occlusion in dogs given perfluorochemical.26 These studies suggest a potential role for perfluorochemical as a therapeutic agent in the treatment of myocardial infarction.
Effect of intracoronary perfluorochemical on infarct size and left ventricular function. Our results demonstrate that administration of low-dose (15 ml/kg) intracoronary perfluorochemical in an occlusion-reperfusion preparation results in a greater than 50% reduction in infarct size when it is expressed as a percentage of the perfusion bed or as a percentage of total left ventricular mass. The ability of perfluorochemical to reduce infarct size in our study is even more striking considering that this occurred despite the presence of a significantly larger area at risk in the drug-treated group than the controls. Since a major objective of reperfusion is to improve ventricular function, we assessed regional myocardial shortening as an estimate of contractile state. Morphologic reduction in infarct size was associated with a significant improvement in contractile function in the jeopardized zone at 24 hr after reperfusion. In the conscious dog preparation, maximal return of ventricular function occurs only at 4 weeks after reperfusion; the degree of salvage and return of function appears to parallel the duration of occlusion.33 14 Myocardial function in the ischemic areas returns to normal once cellular integrity has been restored. The term "stunned myocardium" has been applied to this markedly delayed return of function. 37 In man Stack et al.' were able to demonstrate greater improvement in regional wall motion at 16 days compared with 24 hr in patients who had undergone successful reperfusion with streptokinase. Hence, it is conceivable that a sig- nificant amount of myocardium in this study remained "stunned" and that even greater improvement in regional wall motion would be found if the animals were studied later. Infusion of intracoronary perfluorochemical did not cause a significant increase in pulmonary A capillary wedge pressure, nor did it increase the propensity toward reperfusion arrhythmias.
Comparisons with other studies. The potential use of perfluorochemicals in reducing infarct size has been assessed in numerous preparations. Glogar 1.00 (8) T SEM <<! 050D '~~~ps <5 (8) 2 _i -j 0.75 -(8) N a -~~~~~~~~~~~~~ (8) E: u-0.25 (8) found that pretreatment with perfluorochemical in a preparation of permanent occlusion significantly reduced infarct size in dogs. Chun et al.24 demonstrated that baboons undergoing left anterior descending ligation for 15 min had a significant reduction in infarct size compared with controls. Nunn et al. 25 found a 25% reduction in infarct size 6 hr after infarction in a preparation of permanent occlusion in dogs given 30 ml/kg of Fluosol. We have also observed a significant reduction in infarct size in a 3 day preparation of permanent occlusion in dogs given large doses of perfluorochemical after 30 min of occlusion. 38 Detailed histologic assessment revealed greater epicardial sparing and less inflammatory infiltration in the marginal zones. This study demonstrates that small doses of perfluorochemical given directly into the coronary artery in a preparation of occlusion-reperfusion will result in even greater myocardial salvage. By use of the coronary route of administration volume overload and an exchange blood transfusion can be avoided.
Mechanisms of myocardial salvage by perfluorochemi-
cal. The exact mechanisms by which perfluorochemicals reduce infarct size remains a matter for speculation. Although microsphere measurements in our study indicated significantly greater regional blood flow immediately after reperfusion in the group treated with perfluorochemical, this difference was not maintained 1 hr after reperfusion. Rude et al.27' 39 have also shown augmented oxygen availability in the central ischemic zone in animals treated with perfluorochemi-1066 cal and that this increased oxygen delivery in a nonischemic preparation was not the result of a decrease in left ventricular myocardial oxygen demand. The exact mechanism of action of perfluorochemical, however, remains unknown. Kloner et al. 40 have examined the effects of 40 and 90 min of occlusion on the microvascular circulation and the no-reflow phenomenon. No reflow occurred after only 40 min of occlusion and was associated with severe capillary damage. We have observed in a preparation of permanent occlusion that perfluorochemicals are taken up by endothelial cells. 38 These cells have been shown to release a substance, endothelialderived relaxation factor, which modulates the reactivity of the coronary vascular bed to various endogenous substances.41-3 Hence, it is possible that perfluorochemicals, by preserving the function and integrity of the endothelium, abolish this no-reflow phenomenon.
Engler et al. 44 have shown extensive leukocyte plugging in the area of no reflow and suggested that this was the cause of the no-reflow phenomenon. Two perfluorochemicals, oxypherol and Fluosol, have been reported by us to inhibit neutrophil phagocytosis, chemotaxis, and superoxide release. 4546 We have also demonstrated that perfluorochemicals decrease the polymorphonuclear infiltration in the marginal subendocardial and subepicardial zones in a 3 day preparation of permanent occlusion.38 Neutrophils produce large numbers of oxygen-free radicals and these have recently been proposed as an important pathogenetic CIRCULATION B C LATERAL ZONE -FLUOSOL --CONTROL T SEM * p<.05 (5) 
mechanism in reperfusion injury. 18 47 Free-radical scavenger enzymes have also been shown to limit infarct size if given before or soon after reperfusion. 17 In a preparation of reperfusion in vitro, the addition of oxygen free-radical scavengers provides no further augmentation of ventricular function as compared with that provided by perfluorochemical alone.48 Therefore, perfluorochemical may reduce reperfusion injury by preventing formation of free radicals and/or leukocyte plugging of the microcirculation.
Microvascular blood flow during myocardial ischemia may also be compromised by platelet activation and release of platelet byproducts.495' During ischemia leakage of numerous lysosomal enzymes occur that may also limit capillary blood flow by producing interstitial edema.52' 53 The effect of perfluorochemical on these mechanisms remains unknown.
In conclusion, low doses (15 ml/kg) of intracoronary perfluorochemical markedly reduce infarct size in a preparation of reperfusion without significantly increasing pulmonary capillary wedge pressure. Reduction of infarct size is associated with improvement of the fractional shortening in the jeopardized zone 24 hr after reperfusion. These results suggest that perfluorochemicals are potentially useful therapeutic agents in salvaging ischemic myocardium after successful thrombolytic therapy.
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